Overview

Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare

Status:
Not yet recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to investigate the efficacy and safety of dapansutrile (OLT1177®) tablets in subjects with an acute gout flare.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Olatec Therapeutics LLC
Treatments:
Dapansutrile